Skip to main content
profile image
Selected Works of Samer Nakhle, MD, FACE
Article
Tildacerfont in Adults with Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies.
The Journal of Clinical Endocrinology and Metabolism (2021)
  • Kyriakie Sarafoglou, University of Minnesota
  • Chris N Barnes, Spruce Biosciences, Inc., Daly City, CA.
  • Michael Huang, Former employee of Spruce Biosciences, Inc.
  • Erik A Imel, Indiana University
  • Ivy-Joan Madu, Diabetes Associates Medical Group, Orange, CA.
  • Deborah P Merke, National Institutes of Health
  • David Moriarty, Spruce Biosciences, Inc., Daly City, CA.
  • Samer Nakhle, Palm Medical Group, Las Vegas, NV.
  • Ron S Newfield, University of California, San Diego
  • Maria G Vogiatzi, Children's Hospital of Philadelphia
  • Richard J Auchus, University of Michigan
Link
Disciplines
Publication Date
June 19, 2021
DOI
10.1210/CLINEM/DGAB438
Citation Information
Kyriakie Sarafoglou, Chris N Barnes, Michael Huang, Erik A Imel, et al.. "Tildacerfont in Adults with Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies." The Journal of Clinical Endocrinology and Metabolism (2021)
Available at: http://works.bepress.com/samer-nakhle/2/